Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

about

First MEPS/HPLC assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma

P2860

Q57585606-B7F97AF7-7DC6-48FF-9AE4-5B3216544919

P2860

Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

Item

http://www.wikidata.org/entity/Q35970340

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

@ast

Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

@en

type

Item

label

Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

@ast

Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

@en

prefLabel

Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

@ast

Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

@en

P1476

Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

@en

P2860

Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data.

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors

Venlafaxine serum levels and CYP2D6 genotype

Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression.

Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC.

Postmortem tissue concentrations of venlafaxine.

Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors.

Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients.

P304

1212-1218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/CCLM.2004.243

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Philip B. Mitchell

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15576285

http://www.w3.org/2001/XMLSchema#string

Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

about

P2860

P2860

Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698